Home › Companies › AXSOME THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and AXSOME THERAPEUTICS INC.’s Form 8-K, filed June 11, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 7, 2024: 4 items on AXSOME THERAPEUTICS INC.’s Form 8-K, filed June 11, 2024: 2 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AXSOME THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AXSOME THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Herriot Tabuteau, M.D. | 33,257,792 | -- | -- | 526,545 | 6,137,450 | 98% | Elected | — |
| Elect Director: Mark Coleman, M.D. | 27,121,859 | -- | -- | 6,662,478 | 6,137,450 | 80% | Elected | — |
| 2. Ratification of Appointment of Deloitte & Touche LLP | 39,146,384 | 153,117 | 622,286 | -- | 0 | 99.6% | Approved | — |
| 3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's Named Executive Officers | 32,850,943 | 866,046 | 67,348 | -- | 6,137,450 | 97% | Approved | — |
Source: AXSOME THERAPEUTICS INC., Form 8-K, filed with the SEC on June 11, 2024 — read the filing on EDGAR.
Each item below shows how the 263 asset managers that disclosed a AXSOME THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Herriot Tabuteau, M.D.
AXSOME THERAPEUTICS INC.’s own tally for this item (“Elect Director: Herriot Tabuteau, M.D.”): 33,257,792 for, 526,545 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the following directors to serve as Class III directors until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 484,796 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 466,323 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 446,986 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 302,849 | 0 | 0 | 0 | For |
| Waddell & Reed | 199,260 | 0 | 0 | 0 | For |
| Loomis Sayles | 160,400 | 0 | 0 | 0 | For |
| State Street | 135,929 | 0 | 0 | 98 | For |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 65,263 | 0 | 0 | 0 | For |
| First Trust | 52,484 | 0 | 0 | 0 | For |
| Equitable | 49,433 | 0 | 0 | 0 | For |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 43,602 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 43,297 | 0 | 0 | 0 | For |
| Allspring | 41,059 | 0 | 0 | 0 | For |
| MoA Funds Corp | 41,005 | 0 | 0 | 0 | For |
| Lincoln Financial | 40,227 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 32,494 | 0 | 0 | 0 | For |
Fund voting reports, all 77 managers: 7,298,109 for, 19,350 withheld. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 120,000 | 0 | 0 | 0 | For |
| Keel Point, LLC | 67 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 120,067 for.
Combines 5 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Mark Coleman, M.D.
AXSOME THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mark Coleman, M.D.”): 27,121,859 for, 6,662,478 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the following directors to serve as Class III directors until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 484,796 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 466,323 | Withhold |
| MUTUAL FUND SERIES TRUST | 414,486 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 302,849 | Withhold |
| Waddell & Reed | 0 | 0 | 0 | 199,260 | Withhold |
| Loomis Sayles | 0 | 0 | 160,400 | 0 | Abstain |
| State Street | 289 | 0 | 0 | 135,738 | Withhold |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 65,263 | Withhold |
| First Trust | 0 | 0 | 0 | 52,484 | Withhold |
| Equitable | 9,353 | 0 | 0 | 40,080 | Mixed |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 43,602 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 43,297 | Withhold |
| Allspring | 0 | 0 | 0 | 41,059 | Withhold |
| MoA Funds Corp | 0 | 0 | 0 | 41,005 | Withhold |
| Lincoln Financial | 10,527 | 0 | 0 | 29,700 | Mixed |
| CARILLON SERIES TRUST | 0 | 0 | 32,494 | 0 | Abstain |
Fund voting reports, all 77 managers: 4,878,217 for, 2,184,068 withheld, 222,674 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 120,000 | 0 | 0 | 0 | For |
| Keel Point, LLC | 0 | 67 | 0 | 0 | Against |
Institutional-manager reports, all 2 managers: 120,000 for, 67 against.
Combines 13 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To approve, by non-binding advisory vote, the compensation of our named executive officers.
AXSOME THERAPEUTICS INC.’s own tally for this item (“3. Approval, by Non-Binding Advisory Vote, of the Compensation of the Company's Named Executive Officers”): 32,850,943 for, 866,046 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders voted to approve, by non-binding advisory vote, the compensation of the Company's named executive officers.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 388,903 | 95,893 | 0 | 0 | Mixed |
| Delaware/Macquarie | 466,323 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 446,986 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 302,849 | 0 | 0 | 0 | For |
| Waddell & Reed | 199,260 | 0 | 0 | 0 | For |
| Loomis Sayles | 160,400 | 0 | 0 | 0 | For |
| State Street | 135,942 | 85 | 0 | 0 | For |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 65,263 | 0 | 0 | 0 | For |
| First Trust | 52,484 | 0 | 0 | 0 | For |
| Equitable | 49,433 | 0 | 0 | 0 | For |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 43,602 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 43,297 | 0 | 0 | 0 | For |
| Allspring | 41,059 | 0 | 0 | 0 | For |
| MoA Funds Corp | 41,005 | 0 | 0 | 0 | For |
| Lincoln Financial | 40,227 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 32,494 | 0 | 0 | 0 | For |
Fund voting reports, all 78 managers: 7,221,746 for, 99,955 against, 3,039 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 2,360,077 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 2,269,618 | 0 | 0 | 0 | For |
| Putnam | 1,043,250 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 1,000,000 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 795,372 | 0 | 0 | 0 | For |
| State Street | 781,391 | 163 | 0 | 0 | For |
| BlackRock | 770,938 | 4,074 | 0 | 0 | For |
| Deep Track Capital, LP | 770,436 | 0 | 0 | 0 | For |
| Invesco | 404,420 | 109,525 | 0 | 0 | Mixed |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 471,954 | 0 | 0 | 0 | For |
| Wellington | 447,039 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 394,995 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 365,775 | 0 | 0 | 0 | For |
| Fidelity | 317,220 | 0 | 0 | 0 | For |
| Charles Schwab | 302,850 | 0 | 0 | 0 | For |
| Point72 | 297,338 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 254,535 | 0 | 0 | 0 | For |
| Loomis Sayles | 242,405 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 215,097 | 0 | 0 | 0 | For |
| Northern Trust | 208,819 | 25 | 0 | 0 | For |
| JPMorgan | 168,370 | 0 | 0 | 0 | For |
| EAGLE ASSET MANAGEMENT INC | 167,661 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 155,734 | 0 | 0 | 0 | For |
| Citadel | 139,339 | 0 | 0 | 0 | For |
| US BANK NATIONAL ASSOCIATION | 132,307 | 0 | 0 | 0 | For |
Institutional-manager reports, all 204 managers: 16,679,270 for, 390,686 against, 4,000 withheld, 803 not voted. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
AXSOME THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of Deloitte & Touche LLP”): 39,146,384 for, 153,117 against — passed, per its Form 8-K filed June 11, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,358,590 | 0 | 0 | 0 | For |
| Invesco | 484,796 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 466,323 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 446,986 | 0 | 0 | 0 | For |
| BlackRock | 408,230 | 0 | 0 | 0 | For |
| Charles Schwab | 302,849 | 0 | 0 | 0 | For |
| Waddell & Reed | 199,260 | 0 | 0 | 0 | For |
| Loomis Sayles | 160,400 | 0 | 0 | 0 | For |
| State Street | 136,027 | 0 | 0 | 0 | For |
| JPMorgan | 132,903 | 0 | 0 | 0 | For |
| Putnam | 100,300 | 0 | 0 | 0 | For |
| Fidelity | 85,213 | 0 | 0 | 0 | For |
| Hartford | 82,705 | 0 | 0 | 0 | For |
| Legg Mason | 73,500 | 0 | 0 | 0 | For |
| DWS | 65,263 | 0 | 0 | 0 | For |
| First Trust | 52,484 | 0 | 0 | 0 | For |
| Equitable | 49,433 | 0 | 0 | 0 | For |
| Northwestern Mutual | 48,689 | 0 | 0 | 0 | For |
| Neuberger Berman | 45,528 | 0 | 0 | 0 | For |
| TIAA | 43,602 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 43,297 | 0 | 0 | 0 | For |
| Allspring | 41,059 | 0 | 0 | 0 | For |
| MoA Funds Corp | 41,005 | 0 | 0 | 0 | For |
| Lincoln Financial | 40,227 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 32,494 | 0 | 0 | 0 | For |
Fund voting reports, all 76 managers: 7,301,058 for, 12,523 against, 3,039 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 120,000 | 0 | 0 | 0 | For |
| HOWLAND CAPITAL MANAGEMENT LLC | 1,380 | 0 | 0 | 0 | For |
| Keel Point, LLC | 67 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 121,447 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 47,464,575 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.08% |
| 2 | Invesco | 1.02% |
| 3 | Delaware/Macquarie | 0.98% |
| 4 | MUTUAL FUND SERIES TRUST | 0.94% |
| 5 | BlackRock | 0.86% |
| 6 | Charles Schwab | 0.64% |
| 7 | Waddell & Reed | 0.42% |
| 8 | Loomis Sayles | 0.34% |
| 9 | State Street | 0.29% |
| 10 | JPMorgan | 0.28% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fairmount Funds Management LLC | 4.97% |
| 2 | RTW INVESTMENTS, LP | 4.78% |
| 3 | Putnam | 2.20% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 2.11% |
| 5 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1.68% |
| 6 | State Street | 1.65% |
| 7 | BlackRock | 1.63% |
| 8 | Deep Track Capital, LP | 1.62% |
| 9 | Invesco | 1.08% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.99% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Herriot Tabuteau, M.D. | 19.31% | DEF14A |
| Antecip Capital LLC | 15.47% | DEF14A |
| RTW Investments, LP | 9.46% | DEF14A |
| Vanguard Group | 8.81% | 13F |
| BlackRock | 7.99% | 13F |
| Citadel Advisors | 2.74% | 13F |
| State Street | 1.98% | 13F |
| FMR (Fidelity) | 1.95% | 13F |
| Geode Capital | 1.78% | 13F |
| Millennium Management | 1.59% | 13F |
Percentages above are of 47,464,575 shares outstanding, as reported by AXSOME THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AXSOME THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At AXSOME THERAPEUTICS INC.'s shareholder meeting held June 7, 2024, in the 2023-2024 proxy season, 263 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,152 separate fund positions. On the most widely held item on that ballot — To approve, by non-binding advisory vote, the compensation of our named executive officers. — AXSOME THERAPEUTICS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AXSOME THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2024.
AXSOME THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.